- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03520725
Antioxidant Capacity and Vitamin A Profile in Young Adults Who Consume a Snack Bar Made From Tropical Fruits Treated With UV-C
April 27, 2018 updated by: Humberto Francisco Astiazaran Garcia, PhD, Centro de Investigación en Alimentación y Desarrollo A.C.
Antioxidant Capacity and Vitamin A Profile in Young Adults Who Consume a Snack Bar Made From Tropical Fruits Treated With UV-C.
The objective of the present study was to evaluate the impact of a snack bar on some health indicators associated with diet (plasma antioxidant capacity, lipid profile, vitamin A profile (retinol and carotenoids)) and on the nutritional status (impact on energy and nutrients consumed) in a group of upper level students.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A blind randomized controlled clinical study of healthy adults, which was carried out with the approval of the ethics committee of the Centro de Investigación en Alimentación y Desarrollo, A.C. (CIAD, A.C.) with registration CE/001/2017.
The intervention was carried out in a public university in Mexico from January to April 2017.
Each subject signed an informed consent form.
This study lasted 30 days (4 weeks), where each participant consumed daily a snack bar irradiated with UV-C.
The participants were personally interviewed by the research team with a structured selection questionnaire.
Thirty subjects who met the inclusion criteria were recruited, 15 of them men and 15 women.
Through a simple randomization process, the participants were assigned in 3 groups of 10 people each with 5 women and 5 men, subsequently treatments (without treatment, pineapple snack bar, or mango snack bar) were randomly assigned.
The outcomes between groups were analyzed with one way ANOVA, with a P-value of 0.05 or less when there was statistical significance, using statistical software.
The participants, and the laboratory technicians were blinded to the treatment assignments until the conclusion of the trial.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 28 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Young adults of 18 years of age or older,
- Healthy in appearance
Exclusion Criteria:
- People in current medical treatment
- Used antibiotics in past 15 days
- Have presented infectious symptoms on previous days
- Smokers
- Narcotic consumers
- Women in use of hormonal treatment
- Contraceptives or pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: No Intervention
This group did not have an intervention
|
This gruop did not have an intervention
|
Experimental: Intervention pineapple
Daily consumption of 30 g of pineapple snack bar for 4 weeks.
|
30 g daily of pineapple snack bar
|
Experimental: Intervention mango
Daily consumption of 30 g of mango snack bar for 4 weeks.
|
30 g daily of mango snack bar
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change Oxygen Radical Absorbance Capacity Assay (Antioxidant Capacity)
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Trolox Equivalent Antioxidant Capacity (Antioxidant Capacity)
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Serum Retinol Determination
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Serum pro-VA carotenoids
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change Serum total polyphenols determination
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Serum cholesterol determination
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Serum Triacylglycerides determination
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Serum high density lipoprotein cholesterol
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Body Mass Index
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Body composition by fat-free mass index
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
Change Body composition by fat mass index
Time Frame: Change from baseline at thirty days
|
From baseline and thirty days post treatment
|
Change from baseline at thirty days
|
24-hour dietary recall
Time Frame: Baseline and thirty days
|
From baseline and thirty days post treatment
|
Baseline and thirty days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2016
Primary Completion (Actual)
April 1, 2017
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
February 23, 2018
First Submitted That Met QC Criteria
April 27, 2018
First Posted (Actual)
May 11, 2018
Study Record Updates
Last Update Posted (Actual)
May 11, 2018
Last Update Submitted That Met QC Criteria
April 27, 2018
Last Verified
January 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HFAG001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
The data base will not be shared, each collaborator will participate verifying the handling of the samples and the process of analysing the results in a blinded manner.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nutritional and Metabolic Disease
-
Hadassah Medical OrganizationRecruitingSedentary Behavior | Nutritional and Metabolic DiseaseIsrael
-
Physicians Committee for Responsible MedicineCompletedDietary Modification | Nutritional and Metabolic DiseaseUnited States
-
Clinical Nutrition Research Center, Illinois Institute...California Strawberry CommissionCompletedInsulin Resistance | Metabolic Disease | Nutritional DiseaseUnited States
-
Isfahan University of Medical SciencesCompletedNutritional and Metabolic DiseaseIran, Islamic Republic of
-
Yonsei UniversityUnknownCardiovascular Disease | Metabolic DiseaseKorea, Republic of
-
Clinical Nutrition Research Centre, SingaporeCompletedCardiovascular Disease | Metabolic Disease
-
University of GuadalajaraCompletedNutritional and Metabolic DiseaseMexico
-
Clinical Nutrition Research Center, Illinois Institute...GlaxoSmithKlineCompletedOverweight | Nutritional and Metabolic DiseaseUnited States
-
University Hospitals Coventry and Warwickshire...University of WarwickNot yet recruiting
-
University Hospital, LilleRecruiting
Clinical Trials on No Intervention
-
Wave NeuroscienceCompletedAutistic DisorderUnited States
-
University of Alabama at BirminghamCompletedInflammatory Bowel Diseases | Colorectal Cancer | Diverticular Diseases | Social BehaviorUnited States
-
Janssen Research & Development, LLCCompletedLupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous | Lupus Erythematosus, DiscoidUnited States, Poland
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Southern California College of Optometry at Marshall...Ohio State University; University of Houston; Alcon Research; University of Waterloo and other collaboratorsCompletedContact Lens Complication | Contact Lens Acute Red Eye | Contact Lens Related Corneal Infiltrate (Disorder) | Contact Lens-Induced Corneal Fluorescein StainingUnited States, Canada
-
University of Dublin, Trinity CollegeCompleted
-
Hôpital Necker-Enfants MaladesUnknown
-
China Medical University HospitalUnknownIntention to Stay, Turnover Behavior
-
Medical Corps, Israel Defense ForceUnknownMusculoskeletal Disorders | Upper Extremity Pain ChronicIsrael